Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Jeffrey Swigris

Concepts (324)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Idiopathic Pulmonary Fibrosis
46
2019
505
8.920
 Why?
Lung Diseases, Interstitial
39
2019
508
6.310
 Why?
Pulmonary Fibrosis
19
2019
323
5.170
 Why?
Quality of Life
30
2019
2353
3.840
 Why?
Oxygen Inhalation Therapy
10
2019
129
3.380
 Why?
Dyspnea
18
2019
211
3.340
 Why?
Surveys and Questionnaires
29
2019
4624
2.550
 Why?
Connective Tissue Diseases
13
2019
71
2.520
 Why?
Vital Capacity
25
2019
255
2.050
 Why?
Lymphangioleiomyomatosis
4
2015
27
1.470
 Why?
Pyridones
8
2018
123
1.350
 Why?
Anti-Inflammatory Agents, Non-Steroidal
8
2018
299
1.330
 Why?
Walking
7
2013
422
1.290
 Why?
Lung
17
2018
3561
1.160
 Why?
Aged
56
2019
19074
1.130
 Why?
Arthritis, Rheumatoid
7
2018
1003
1.120
 Why?
Patients
3
2018
163
1.070
 Why?
Respiratory Function Tests
16
2019
522
1.070
 Why?
Middle Aged
65
2019
26738
1.060
 Why?
Research Design
5
2016
928
1.040
 Why?
Health Care Costs
3
2018
381
1.010
 Why?
Exercise Test
8
2018
544
0.980
 Why?
Health Status Indicators
4
2014
156
0.980
 Why?
Alveolitis, Extrinsic Allergic
4
2019
86
0.980
 Why?
Humans
117
2019
114705
0.940
 Why?
Sarcoidosis
4
2016
135
0.870
 Why?
Male
74
2019
55607
0.860
 Why?
Female
77
2019
59521
0.840
 Why?
Patient Outcome Assessment
2
2014
122
0.830
 Why?
Mycophenolic Acid
4
2016
77
0.830
 Why?
Patient Reported Outcome Measures
4
2018
250
0.800
 Why?
Severity of Illness Index
16
2018
2540
0.780
 Why?
Internet
2
2016
596
0.770
 Why?
Exercise Tolerance
3
2018
213
0.760
 Why?
Oxygen
4
2018
854
0.730
 Why?
Disease Progression
14
2019
2380
0.730
 Why?
Forced Expiratory Volume
10
2017
475
0.700
 Why?
Undifferentiated Connective Tissue Diseases
1
2019
1
0.660
 Why?
Qualitative Research
4
2017
936
0.620
 Why?
Indoles
2
2018
304
0.600
 Why?
Cough
4
2019
107
0.580
 Why?
Emphysema
1
2018
107
0.580
 Why?
Lung Diseases
3
2015
701
0.550
 Why?
Chronic Disease
4
2018
1578
0.550
 Why?
Lung Transplantation
1
2019
246
0.550
 Why?
Psychometrics
8
2017
608
0.540
 Why?
Immunosuppressive Agents
4
2016
646
0.540
 Why?
Heart Rate
2
2011
709
0.540
 Why?
Pulmonary Medicine
2
2015
87
0.530
 Why?
Ambulatory Care
2
2018
478
0.510
 Why?
Pulmonary Emphysema
1
2018
272
0.500
 Why?
Idiopathic Interstitial Pneumonias
6
2017
46
0.500
 Why?
Information Seeking Behavior
1
2016
35
0.500
 Why?
Narration
1
2016
44
0.500
 Why?
Longitudinal Studies
8
2019
2387
0.480
 Why?
Biomedical Research
2
2018
585
0.460
 Why?
Kaplan-Meier Estimate
8
2018
811
0.460
 Why?
Fatigue
6
2019
294
0.460
 Why?
Caregivers
3
2017
717
0.460
 Why?
Autoimmunity
2
2019
813
0.460
 Why?
Autoimmune Diseases
3
2016
382
0.450
 Why?
Reproducibility of Results
11
2019
2765
0.450
 Why?
Patient-Centered Care
1
2018
473
0.430
 Why?
Social Support
2
2019
528
0.430
 Why?
Social Media
1
2016
131
0.430
 Why?
Antitussive Agents
1
2013
8
0.430
 Why?
Tomography, X-Ray Computed
12
2018
2286
0.420
 Why?
Pulmonary Disease, Chronic Obstructive
2
2019
916
0.420
 Why?
Motivation
1
2017
494
0.420
 Why?
Thalidomide
1
2013
29
0.420
 Why?
Lung Neoplasms
3
2014
2177
0.420
 Why?
Bronchiolitis Obliterans
1
2013
66
0.410
 Why?
Prognosis
12
2018
3330
0.410
 Why?
United States
21
2019
12186
0.410
 Why?
Follow-Up Studies
9
2018
4411
0.400
 Why?
Aged, 80 and over
16
2017
6347
0.400
 Why?
Survival Rate
6
2018
1644
0.400
 Why?
Patient Participation
1
2015
359
0.400
 Why?
Bronchial Diseases
1
2012
38
0.390
 Why?
Treatment Outcome
16
2018
9088
0.380
 Why?
Hospitalization
3
2017
1752
0.380
 Why?
Health Knowledge, Attitudes, Practice
2
2018
1183
0.370
 Why?
Quality Indicators, Health Care
1
2014
287
0.370
 Why?
Adult
31
2019
30553
0.360
 Why?
Pulmonary Diffusing Capacity
6
2017
60
0.360
 Why?
Health Status
5
2019
722
0.360
 Why?
Retrospective Studies
21
2019
12556
0.360
 Why?
Multivariate Analysis
5
2017
1430
0.350
 Why?
Peptides, Cyclic
1
2012
253
0.350
 Why?
Motor Activity
1
2014
640
0.340
 Why?
Endothelins
1
2010
61
0.330
 Why?
Cause of Death
6
2019
361
0.330
 Why?
Scleroderma, Systemic
3
2017
96
0.330
 Why?
Gastroesophageal Reflux
1
2012
234
0.330
 Why?
Activities of Daily Living
3
2018
349
0.320
 Why?
Pulmonary Embolism
1
2011
181
0.320
 Why?
Autoantibodies
4
2015
1346
0.320
 Why?
Sleep Apnea, Obstructive
1
2012
196
0.320
 Why?
TRPP Cation Channels
1
2009
63
0.310
 Why?
Amino Acyl-tRNA Synthetases
3
2016
28
0.310
 Why?
Endothelin-1
1
2010
168
0.300
 Why?
Polycystic Kidney Diseases
1
2009
55
0.300
 Why?
Randomized Controlled Trials as Topic
5
2017
1214
0.290
 Why?
Proportional Hazards Models
3
2017
1075
0.290
 Why?
Prevalence
5
2018
2251
0.280
 Why?
Hypertension, Pulmonary
3
2017
1729
0.270
 Why?
Tumor Suppressor Proteins
1
2009
282
0.270
 Why?
Mortality
4
2019
287
0.270
 Why?
Sex Distribution
3
2012
337
0.270
 Why?
Biopsy
7
2016
1036
0.270
 Why?
Quality Improvement
1
2014
950
0.270
 Why?
Cost of Illness
3
2018
254
0.260
 Why?
Double-Blind Method
6
2017
1660
0.260
 Why?
Lupus Erythematosus, Systemic
1
2008
219
0.250
 Why?
Thrombosis
1
2008
298
0.230
 Why?
Databases, Factual
3
2019
1125
0.230
 Why?
Prospective Studies
8
2019
6220
0.230
 Why?
Time Factors
7
2019
6116
0.230
 Why?
Vascular Endothelial Growth Factor D
2
2013
12
0.220
 Why?
Oxygen Consumption
2
2017
588
0.220
 Why?
Myositis
2
2016
44
0.210
 Why?
Diagnosis, Differential
6
2016
1342
0.210
 Why?
Palliative Care
2
2019
644
0.200
 Why?
Incidence
3
2018
2313
0.190
 Why?
Patient Satisfaction
2
2016
578
0.190
 Why?
Focus Groups
3
2016
383
0.180
 Why?
Sex Factors
5
2016
1715
0.180
 Why?
Registries
3
2019
1768
0.180
 Why?
Age Distribution
2
2012
342
0.180
 Why?
Cohort Studies
5
2019
4895
0.180
 Why?
Logistic Models
4
2019
1841
0.170
 Why?
Linear Models
3
2019
768
0.170
 Why?
Analysis of Variance
3
2015
1226
0.170
 Why?
Survival Analysis
3
2017
1211
0.170
 Why?
Walk Test
2
2017
52
0.170
 Why?
Antibodies, Antinuclear
4
2016
58
0.170
 Why?
Exercise
3
2019
1644
0.170
 Why?
Sensitivity and Specificity
3
2015
1694
0.170
 Why?
Risk Factors
7
2017
8632
0.160
 Why?
Chi-Square Distribution
2
2011
493
0.160
 Why?
Anxiety
3
2019
840
0.160
 Why?
Pulmonologists
1
2018
16
0.160
 Why?
Insurance Claim Review
1
2018
67
0.150
 Why?
Accelerometry
2
2019
73
0.150
 Why?
Cross-Sectional Studies
4
2019
4410
0.150
 Why?
Cellular Senescence
1
2019
152
0.150
 Why?
Weight-Bearing
1
2018
164
0.140
 Why?
Attitude to Health
2
2014
406
0.140
 Why?
Germany
1
2017
84
0.140
 Why?
Sulfonamides
2
2010
445
0.140
 Why?
Antihypertensive Agents
2
2010
429
0.140
 Why?
Medicare
2
2018
665
0.140
 Why?
Perception
1
2019
311
0.130
 Why?
Host-Pathogen Interactions
1
2019
295
0.130
 Why?
Common Variable Immunodeficiency
1
2016
24
0.130
 Why?
Tidal Volume
1
2016
75
0.130
 Why?
Muscle Strength
2
2015
271
0.130
 Why?
Granuloma
1
2016
83
0.130
 Why?
Cyclophosphamide
1
2016
217
0.130
 Why?
Interviews as Topic
2
2016
583
0.130
 Why?
Home Care Services
1
2018
223
0.130
 Why?
Health Policy
1
2018
334
0.130
 Why?
Patient Education as Topic
2
2019
680
0.120
 Why?
Physical Conditioning, Human
1
2015
27
0.120
 Why?
Case-Control Studies
4
2019
3003
0.120
 Why?
Rituximab
1
2016
150
0.120
 Why?
Recovery of Function
1
2018
574
0.120
 Why?
Sarcoidosis, Pulmonary
1
2015
58
0.120
 Why?
Neuroendocrine Cells
1
2015
30
0.120
 Why?
Geographic Information Systems
1
2014
37
0.120
 Why?
Enzyme Inhibitors
2
2016
750
0.120
 Why?
Controlled Clinical Trials as Topic
1
2013
27
0.110
 Why?
Phenotype
2
2018
2797
0.110
 Why?
Information Dissemination
1
2016
186
0.110
 Why?
Sildenafil Citrate
1
2013
57
0.110
 Why?
Antifibrinolytic Agents
1
2014
50
0.110
 Why?
Self Report
2
2019
696
0.110
 Why?
Endpoint Determination
1
2013
68
0.110
 Why?
Sulfones
1
2013
97
0.110
 Why?
Occupational Exposure
1
2016
255
0.110
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2013
39
0.110
 Why?
Adaptation, Psychological
1
2017
547
0.100
 Why?
Antibiotics, Antineoplastic
1
2013
109
0.100
 Why?
Purines
1
2013
159
0.100
 Why?
Patient Dropouts
1
2013
66
0.100
 Why?
Young Adult
5
2017
10471
0.100
 Why?
Sirolimus
1
2013
181
0.100
 Why?
Histocompatibility Antigens Class II
1
2013
352
0.100
 Why?
Pulmonary Gas Exchange
1
2012
117
0.100
 Why?
Vasodilator Agents
1
2013
302
0.100
 Why?
Health Care Surveys
1
2014
539
0.100
 Why?
Delivery of Health Care
1
2018
833
0.100
 Why?
Exercise Therapy
1
2015
352
0.100
 Why?
Minnesota
1
2012
134
0.100
 Why?
Fear
1
2014
293
0.090
 Why?
Piperazines
1
2013
309
0.090
 Why?
Dust
1
2012
84
0.090
 Why?
Consensus
1
2013
537
0.090
 Why?
United Kingdom
1
2012
226
0.090
 Why?
Clinical Trials as Topic
2
2006
932
0.090
 Why?
Hydrogen-Ion Concentration
1
2012
511
0.090
 Why?
Health Surveys
1
2012
443
0.090
 Why?
Pilot Projects
2
2015
1373
0.090
 Why?
Anti-Infective Agents
1
2013
225
0.090
 Why?
Epidemiologic Methods
1
2010
72
0.090
 Why?
Societies, Medical
4
2015
664
0.080
 Why?
Sickness Impact Profile
2
2009
50
0.080
 Why?
Salivary Glands, Minor
1
2009
8
0.080
 Why?
Smoking
2
2017
1383
0.080
 Why?
Sjogren's Syndrome
1
2009
41
0.080
 Why?
Hyperplasia
2
2015
163
0.080
 Why?
International Cooperation
3
2015
171
0.080
 Why?
Oximetry
1
2009
81
0.080
 Why?
Risk
1
2011
812
0.080
 Why?
Europe
3
2015
334
0.080
 Why?
Environmental Exposure
1
2012
372
0.080
 Why?
Scleroderma, Limited
1
2008
5
0.080
 Why?
Depression
2
2019
1134
0.070
 Why?
Poisson Distribution
3
2016
71
0.070
 Why?
Sleep Wake Disorders
1
2011
233
0.070
 Why?
Wound Healing
1
2010
258
0.070
 Why?
Comorbidity
2
2017
1448
0.070
 Why?
Bronchoalveolar Lavage Fluid
1
2010
590
0.070
 Why?
Cardiac Catheterization
1
2011
534
0.070
 Why?
Radiography
2
2016
812
0.070
 Why?
Models, Statistical
1
2011
599
0.070
 Why?
Predictive Value of Tests
2
2009
1796
0.070
 Why?
Pericardium
1
2007
50
0.070
 Why?
Evidence-Based Medicine
1
2011
668
0.070
 Why?
Carbon Monoxide
2
2017
64
0.070
 Why?
Physicians
1
2014
772
0.070
 Why?
Clinical Trials, Phase III as Topic
2
2016
82
0.070
 Why?
Seasons
1
2008
442
0.070
 Why?
Medical Records
1
2006
153
0.060
 Why?
Regression Analysis
3
2016
945
0.060
 Why?
California
1
2005
353
0.060
 Why?
Echocardiography
1
2007
553
0.060
 Why?
Acute Disease
1
2006
911
0.060
 Why?
Data Interpretation, Statistical
2
2018
321
0.050
 Why?
Terminology as Topic
1
2005
187
0.050
 Why?
Lymphoid Tissue
1
2002
62
0.050
 Why?
Patient Selection
1
2005
641
0.050
 Why?
Adolescent
3
2017
17853
0.050
 Why?
Disease Models, Animal
1
2010
3535
0.040
 Why?
Respiratory Therapy
1
2019
19
0.040
 Why?
Pulmonary Surfactant-Associated Protein A
1
2019
24
0.040
 Why?
Occupations
1
2019
36
0.040
 Why?
GTPase-Activating Proteins
1
2019
71
0.040
 Why?
Pulmonary Surfactant-Associated Protein C
1
2019
42
0.040
 Why?
Exoribonucleases
1
2019
40
0.040
 Why?
Blood Gas Analysis
1
2019
72
0.040
 Why?
Minimal Clinically Important Difference
1
2018
10
0.040
 Why?
ATP-Binding Cassette Transporters
1
2019
122
0.040
 Why?
Asthma
1
2011
2029
0.040
 Why?
Telomere-Binding Proteins
1
2019
88
0.040
 Why?
Patient Advocacy
1
2018
66
0.040
 Why?
Watchful Waiting
1
2018
55
0.040
 Why?
DNA Helicases
1
2019
133
0.040
 Why?
Education
1
2018
95
0.040
 Why?
Administrative Claims, Healthcare
1
2017
22
0.040
 Why?
Physical Endurance
1
2019
232
0.040
 Why?
Forecasting
1
2019
330
0.040
 Why?
Mucin-5B
1
2019
183
0.040
 Why?
Needs Assessment
1
2019
314
0.040
 Why?
Telomerase
1
2019
206
0.040
 Why?
Spirometry
1
2017
224
0.030
 Why?
Hypersplenism
1
2016
7
0.030
 Why?
Leukopenia
1
2016
27
0.030
 Why?
Sequence Analysis, DNA
1
2019
723
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2019
439
0.030
 Why?
Banking, Personal
1
2016
3
0.030
 Why?
Social Participation
1
2016
13
0.030
 Why?
Terminal Care
1
2019
213
0.030
 Why?
Creatine Kinase
1
2016
75
0.030
 Why?
Rheumatoid Factor
1
2017
157
0.030
 Why?
Health Care Sector
1
2016
24
0.030
 Why?
Death Certificates
1
2016
30
0.030
 Why?
Health Services Needs and Demand
1
2017
243
0.030
 Why?
Commerce
1
2016
61
0.030
 Why?
Arthritis
1
2016
109
0.030
 Why?
Metals
1
2016
106
0.030
 Why?
International Classification of Diseases
1
2016
116
0.030
 Why?
Promoter Regions, Genetic
1
2019
1131
0.030
 Why?
Multiple Pulmonary Nodules
1
2015
22
0.030
 Why?
Anthropometry
1
2015
183
0.030
 Why?
Physical Examination
1
2016
222
0.030
 Why?
Genetic Variation
1
2019
870
0.030
 Why?
Disease-Free Survival
1
2016
620
0.030
 Why?
Alberta
1
2013
10
0.030
 Why?
Teaching
1
2016
213
0.030
 Why?
Bronchiolitis
1
2015
81
0.030
 Why?
Mortality, Premature
1
2013
11
0.030
 Why?
Counseling
1
2016
342
0.030
 Why?
RNA
1
2019
809
0.030
 Why?
Odds Ratio
1
2016
953
0.030
 Why?
Genome-Wide Association Study
1
2019
1177
0.030
 Why?
Adrenal Cortex Hormones
1
2016
497
0.030
 Why?
Drug Therapy, Combination
1
2016
951
0.030
 Why?
Inflammation
1
2002
2480
0.030
 Why?
Congresses as Topic
1
2013
195
0.030
 Why?
Administration, Oral
1
2014
728
0.020
 Why?
Age Factors
2
2010
2894
0.020
 Why?
Dose-Response Relationship, Drug
1
2016
1842
0.020
 Why?
Genetic Predisposition to Disease
1
2019
2086
0.020
 Why?
Japan
1
2011
86
0.020
 Why?
Antigens, Human Platelet
1
2011
9
0.020
 Why?
Latin America
1
2011
69
0.020
 Why?
Mental Health
1
2016
562
0.020
 Why?
Alanine-tRNA Ligase
1
2009
4
0.020
 Why?
Threonine-tRNA Ligase
1
2009
4
0.020
 Why?
Psychiatric Status Rating Scales
1
2011
482
0.020
 Why?
Animals
1
2010
31709
0.020
 Why?
Syndrome
1
2009
333
0.020
 Why?
DNA Topoisomerases, Type I
1
2008
16
0.020
 Why?
Body Mass Index
1
2015
1959
0.020
 Why?
Cell Proliferation
1
2015
2187
0.020
 Why?
Lymphocytes
1
2009
330
0.020
 Why?
Pulmonary Wedge Pressure
1
2007
63
0.020
 Why?
Muscle, Skeletal
1
2015
1473
0.020
 Why?
Risk Assessment
1
2015
2968
0.020
 Why?
Child
1
2002
18420
0.010
 Why?
Nuclear Proteins
1
2008
591
0.010
 Why?
Biomarkers
1
2013
3408
0.010
 Why?
Pneumonia
1
2008
568
0.010
 Why?
Swigris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (324) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)